Drug profile · INN
peficitinib hydrobromide
SMYRAF
peficitinib hydrobromide (SMYRAF) is an FDA-listed pharmaceutical active ingredient.
PMDA: approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — peficitinib hydrobromide
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.78
Quick answer
peficitinib hydrobromide (SMYRAF) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN peficitinib hydrobromide
Brand SMYRAF
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Pipeline programs
Frequently asked questions
What is peficitinib hydrobromide?
peficitinib hydrobromide (SMYRAF) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for peficitinib hydrobromide?
SMYRAF is a marketed brand name for peficitinib hydrobromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.